Evidence map›Paper›PMID 42761112›Full record

ArticleFrontiers in medicine2026

Case Report: Autoimmune hepatitis following oxaliplatin exposure presenting with multifactorial non-cirrhotic portal hypertension and recurrent parastomal variceal bleeding.

Wei Cheng, Hongbo Shi, Jiaju Fan, Xiaoming He, Haibin Shi, Yi Li, Yunfeng Huan, Shengqin Zhang

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wei Cheng *Department of Gastrointestinal Surgery, The First Affiliated Hospital of Dali University, Dali, Yunnan, China.
Hongbo Shi *Department of Gastrointestinal Surgery, The First Affiliated Hospital of Dali University, Dali, Yunnan, China.
Jiaju Fan *Department of Gynaecology, The First Affiliated Hospital of Dali University, Dali, Yunnan, China.
Xiaoming HeDepartment of Vascular Surgery, The First Affiliated Hospital of Dali University, Dali, Yunnan, China.
Haibin ShiDepartment of Gastrointestinal Surgery, The First Affiliated Hospital of Dali University, Dali, Yunnan, China.
Yi LiDepartment of Gastrointestinal Surgery, The First Affiliated Hospital of Dali University, Dali, Yunnan, China.
Yunfeng HuanDepartment of Gastrointestinal Surgery, The First Affiliated Hospital of Dali University, Dali, Yunnan, China.
Shengqin ZhangDepartment of Gastrointestinal Surgery, The First Affiliated Hospital of Dali University, Dali, Yunnan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ectopic variceal hemorrhage accounts for approximately 5% of all variceal bleeding episodes and represents an uncommon manifestation of portal hypertension. This report describes recurrent parastomal variceal bleeding in a 43-year-old woman with rectal adenocarcinoma who underwent abdominoperineal resection followed by five cycles of oxaliplatin-containing chemotherapy. During chemotherapy, severe hepatocellular injury developed. A liver biopsy performed in June 2020 demonstrated severe interface hepatitis with lymphoplasmacytic portal inflammation, findings that supported a diagnosis of autoimmune hepatitis (AIH). No histopathological features diagnostic of portosinusoidal vascular disease (PSVD) were identified. Subsequently, progressive splenomegaly, gastroesophageal and parastomal varices, and a directly measured portal pressure of 35 cm H

Indexed as

autoimmune hepatitisnon-cirrhotic portal hypertensionoxaliplatinparastomal varicesportal hypertension

Identifiers

PMID42761112
PMCPMC13585593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.